Headache Journal Articles

• Erenumab Dosage for Migraine Prevention Erenumab is used to help prevent migraine headaches, but what is the optimal dosage?
  Headache, May 23, 2022
• MIS in Children After SARS-CoV-2 Vaccination Does COVID-19 vaccination play a role in the pathogenesis of multisystem inflammatory syndrome in children? This report helps further our understanding.
  Emerging Infectious Diseases, May 20, 2022
• Sex Differences in Medical Cannabis-Related Adverse Effects Are women more likely than men to experience adverse effects associated with the use of medical cannabis? A new study investigates.
  Pain, May 19, 2022
• Hospitalizations of Children and Adolescents With COVID-19 This report documents the rapid increase of COVID-19-associated hospitalization among children and adolescents coinciding with the emerging predominance of the Omicron variant.
  Morbidity & Mortality Weekly Report, May 18, 2022
• Emerging Drug Therapies in Inflammatory Bowel Disease Several new IBD drug therapies are currently in early clinical trials, with more in the therapeutic pipeline. Review the latest data in this article.
  Alimentary Pharmacology & Therapeutics, May 18, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Psychological Interventions for Adults With Migraine A new review examines the potential beneficial effects of psychological interventions in adults with migraine.
  Headache, May 16, 2022
• Safety Monitoring of COVID-19 Vaccine Boosters Among Adults Surveillance data confirms the safety of an mRNA COVID-19 booster vaccine, with local and systemic reactions being less frequent than after the second primary vaccine dose.
  Morbidity & Mortality Weekly Report, May 11, 2022
• Manual Therapy in the Treatment of Cervicogenic Headache This study identified various manual therapy methods and techniques that are being evaluated for the treatment of cervicogenic headache. Which have shown the greatest efficacy?
  Headache, May 06, 2022
• Herpetic Anterior Uveitis Following Pfizer COVID-19 Vaccine What are the possible immunological mechanisms by which SARS-CoV-2 vaccination might trigger herpetic reactivation, as in these patients who developed herpetic anterior uveitis after an mRNA vaccine?
  Journal of Medical Case Reports, May 05, 2022
• Receiving Medical Care for Chronic Migraines How can primary care providers improve care for patients with chronic migraine? This study aimed to elucidate patients' experiences and frustrations with current approaches to care.
  Southern Medical Journal, May 05, 2022
• Transcranial Alternating Current Stimulation for Depression This study assessed the efficacy of transcranial alternating current stimulation on first-episode drug-naive patients with major depressive disorder.
  Brain, May 05, 2022
• Rheumatoid Factor Positivity in ANCA-Associated Vasculitis What is the role of rheumatoid factor positivity in ANCA-associated vasculitis? A new study investigates.
  Rheumatology, May 04, 2022
• Dural Arteriovenous Fistula What did imaging studies reveal about the origin of this patient's vertigo, headache, and four-day history of vision changes?
  Applied Radiology, May 03, 2022
• Therapies for Episodic and Chronic Cluster Headache Review the current options for acute and preventive treatments for cluster headache. How might network meta-analyses be used to compare these treatments?
  Headache, April 29, 2022
• Guillain-barre/Miller Fisher Overlap Syndrome After COVID-19 An acute motor sensory axonal neuropathy is a neurological complication that may result from COVID-19-provoked Guillain-barre syndrome, as seen in this patient.
  Journal of Medical Case Reports, April 28, 2022
• Point-of-Care SARS-CoV-2 Antigen Test for Asymptomatic Persons A rapid, high-sensitivity antigen test previously shown to accurately detect SARS-CoV-2 in symptomatic individuals can be used to screen asymptomatic persons as well, according to this study.
  American Journal of Clinical Pathology, April 27, 2022
• Safety and Tolerability of Once Daily BIC/FTC/TAF for PEP Is this PEP regimen a safe and effective means of preventing HIV infection after high-risk sexual exposure?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, April 27, 2022
• Breast Implant Illness: Capsulectomy and Implant Removal Patients experiencing symptoms of breast implant illness could be successfully treated with implant removal with capsulectomy.
  ePlasty, April 26, 2022
• The Multispecialty Toxin: A Literature Review of Botox Learn more about the many clinical applications of botulinum toxin therapy across multiple specialties.
  Plastic Reconstructive Surgery-Global Open (PRS Global Open), April 26, 2022